Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance.
- NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_assertion description "[Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance.
- NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_assertion evidence source_evidence_literature NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance.
- NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_assertion SIO_000772 22391209 NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance.
- NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_assertion wasDerivedFrom befree-20150227 NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance.
- NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_assertion wasGeneratedBy ECO_0000203 NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance.